4.91 USD
▼-0.15-2.96%
盘后 4.84 -1.43%
2026-11-20
市值
$12.80M
市盈率
—
EPS
-16.38
股息率
—
52 周区间
3.10 – 7.78
成交量
60.41K
Beta
0.82
目标价
41.00
52W 低 3.1052W 高 7.78
价格走势
公司简介
Bolt Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company offers product candidates and platform technologies, including PRA-216, BDC-4182, a Boltbody ISAC that targets the tumor-associated antigen claudin 18.2 for the treatment of gastric/gastroesophageal junction cancer, pancreatic cancer, and other tumor types; BDC-3042, a dectin-2 agonist antibody program for the treatment of non-small cell lung cancer, melanoma, and other solid tumors; the Bol...